Evidence map›Paper›PMID 12417573›Full record

ArticleThe Journal of clinical investigation2002

The functional CD8 T cell response to HIV becomes type-specific in progressive disease.

Sang Kyung Lee, Zhan Xu, Judy Lieberman, Premlata Shankar

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sang Kyung LeeCenter for Blood Research and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Zhan Xu
Judy Lieberman
Premlata Shankar
Harvard University Press · USDana-Farber/Boston Children's Cancer and Blood Disorders Center · US

Funding

EFFECTOR/MEMORY CD8 T CELL FUNCTIONS IN HIV INFECTIONR21AI049792 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI SHANKAR, PREMLATA · 2001 to 2001
$426k
CTL LYSIS OF HIV-INFECTED CD4 T CELLS AND MACROPHAGESR21AI045306 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI SHANKAR, PREMLATA · 1999 to 2000
$284k
NIAID NIH HHS AI-45306NIAID NIH HHS AI-49792
6 · The paper itself

Abstract

High levels of HIV-specific CD8 T cells are demonstrable throughout HIV disease using laboratory assays that measure responses to consensus epitopes. In acute infection, the dynamics of the antiviral CD8 T cell response correlate well with the decline in viremia. However in chronic infection, although responses are detected against a broader spectrum of epitopes, virus-specific CD8 T cells are apparently unable to control viral replication. To investigate whether CD8 T cells responding to consensus epitopes may have lost their in vivo relevance in the chronic phase because of viral evolution driven by immune pressure, we compared the CD8 T cell response to CD4 T cell targets infected with either lab-adapted HIV(IIIB) or the patient's own virus. The magnitude of the IFN-gamma response declined with disease progression, especially to autologous virus. T cell receptor (TCR) clonotypes of HIV(IIIB) and autologous virus-responding cells were determined by sequencing TCR beta chain variable (TCRBV) genes. In two of three asymptomatic donors, the dominant clonotypes overlapped, whereas in five symptomatic patients, the TCR clonotypes responding to HIV(IIIB) virus were completely different from those responding to autologous virus. Moreover, in cytolytic assays, T cell lines derived from IFN-gamma(+) cells responding to lab-adapted or autologous virus cross-recognized target cells infected with either virus in asymptomatic subjects with shared TCR clonotypes but not in progressors with differing clonotypes. Therefore, in advanced-stage patients, viral-specific CD8 T cells recognizing consensus epitopes persist from an earlier response but no longer effectively recognize autologous virus.

Indexed as

CD8-Positive T-LymphocytesDisease ProgressionGenes, T-Cell Receptor betaHIVHIV InfectionsHumansInterferon-gammaInterferon-gamma

Identifiers

PMID12417573
PMCPMC151615
OpenAlexW2073556062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.